Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 12 studies | 20% ± 5% | |
memory B cell | 8 studies | 19% ± 3% | |
naive B cell | 7 studies | 20% ± 5% | |
plasmacytoid dendritic cell | 4 studies | 21% ± 5% | |
classical monocyte | 3 studies | 19% ± 3% | |
conventional dendritic cell | 3 studies | 24% ± 6% | |
retinal bipolar neuron | 3 studies | 23% ± 5% | |
retinal ganglion cell | 3 studies | 68% ± 24% | |
epithelial cell | 3 studies | 34% ± 6% | |
amacrine cell | 3 studies | 31% ± 11% | |
retina horizontal cell | 3 studies | 23% ± 8% | |
ciliated cell | 3 studies | 24% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
eye | 3 studies | 20% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2091.92 | 1445 / 1445 | 100% | 20.00 | 183 / 183 |
intestine | 100% | 2501.33 | 966 / 966 | 100% | 28.61 | 527 / 527 |
lung | 100% | 2506.26 | 578 / 578 | 100% | 31.01 | 1155 / 1155 |
ovary | 100% | 2147.82 | 180 / 180 | 100% | 28.07 | 430 / 430 |
pancreas | 100% | 1213.58 | 328 / 328 | 100% | 32.84 | 178 / 178 |
prostate | 100% | 2459.30 | 245 / 245 | 100% | 33.53 | 502 / 502 |
skin | 100% | 2452.17 | 1809 / 1809 | 100% | 32.92 | 472 / 472 |
stomach | 100% | 2008.06 | 359 / 359 | 100% | 24.58 | 286 / 286 |
uterus | 100% | 2243.15 | 170 / 170 | 100% | 32.20 | 459 / 459 |
brain | 100% | 2370.91 | 2638 / 2642 | 100% | 38.03 | 705 / 705 |
thymus | 100% | 2597.77 | 653 / 653 | 100% | 34.11 | 604 / 605 |
bladder | 100% | 2313.19 | 21 / 21 | 100% | 31.00 | 503 / 504 |
adrenal gland | 100% | 2388.20 | 258 / 258 | 100% | 45.62 | 229 / 230 |
breast | 100% | 2271.22 | 459 / 459 | 99% | 29.08 | 1112 / 1118 |
kidney | 100% | 2312.36 | 89 / 89 | 99% | 23.12 | 894 / 901 |
liver | 100% | 1222.31 | 226 / 226 | 99% | 19.50 | 402 / 406 |
adipose | 100% | 2112.77 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2103.99 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 27.09 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 34.44 | 29 / 29 |
spleen | 100% | 3263.44 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 30.39 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 14.35 | 1 / 1 |
muscle | 100% | 1754.44 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1235.16 | 856 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1690.39 | 915 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0046856 | Biological process | phosphatidylinositol dephosphorylation |
GO_1904263 | Biological process | positive regulation of TORC1 signaling |
GO_0006991 | Biological process | response to sterol depletion |
GO_0032418 | Biological process | lysosome localization |
GO_1901796 | Biological process | regulation of signal transduction by p53 class mediator |
GO_0070070 | Biological process | proton-transporting V-type ATPase complex assembly |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005886 | Cellular component | plasma membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0034597 | Molecular function | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PIP4P1 |
Protein name | Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 1 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase I) (Transmembrane protein 55B) Phosphatidylinositol-4,5-bisphosphate 4-phosphatase (EC 3.1.3.78) |
Synonyms | TMEM55B C14orf9 |
Description | FUNCTION: Catalyzes the hydrolysis of phosphatidylinositol-4,5-bisphosphate (PtdIns-4,5-P2) to phosphatidylinositol-4-phosphate (PtdIns-4-P) . Does not hydrolyze phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3,4-bisphosphate, inositol 3,5-bisphosphate, inositol 3,4-bisphosphate, phosphatidylinositol 5-monophosphate, phosphatidylinositol 4-monophosphate and phosphatidylinositol 3-monophosphate . Regulates lysosomal positioning by recruiting JIP4 to lysosomal membranes, thus inducing retrograde transport of lysosomes along microtubules . Contributes to assembly of the V-ATPase complex in lipid rafts of the lysosomal membrane and to subsequent amino acid-dependent activation of mTORC1 . May play a role in the regulation of cellular cholesterol metabolism . . FUNCTION: Catalyzes the hydrolysis of phosphatidylinositol-4,5-bisphosphate (PtdIns-4,5-P2) to phosphatidylinositol-4-phosphate (PtdIns-4-P). . FUNCTION: Catalyzes the hydrolysis of phosphatidylinositol-4,5-bisphosphate (PtdIns-4,5-P2) to phosphatidylinositol-4-phosphate (PtdIns-4-P). . |
Accessions | ENST00000398020.6 [Q86T03-2] ENST00000553460.5 ENST00000708818.1 [Q86T03-2] Q86T03 ENST00000250489.9 [Q86T03-1] H0YJ90 ENST00000708815.1 [Q86T03-1] ENST00000556093.1 G3V5T5 |